Molecular basis of cardiac myxomas.
Cardiac tumors are rare, and of these, primary cardiac tumors are even rarer. Metastatic cardiac tumors are about 100 times more common than the primary tumors. About 90% of primary cardiac tumors are benign, and of these the most common are cardiac myxomas. Approximately 12% of primary cardiac tumors are completely asymptomatic while others present with one or more signs and symptoms of the classical triad of hemodynamic changes due to intracardiac obstruction, embolism and nonspecific constitutional symptoms. Echocardiography is highly sensitive and specific in detecting cardiac tumors. Other helpful investigations are chest X-rays, magnetic resonance imaging and computerized tomography scan. Surgical excision is the treatment of choice for primary cardiac tumors and is usually associated with a good prognosis. This review article will focus on the general features of benign cardiac tumors with an emphasis on cardiac myxomas and their molecular basis.
Department of Pathology, Toronto General Hospital, University Health Network, Toronto, ON M5G2C4, Canada. pooja.singhal@mail.utoronto.ca.
Pooja
P
Singhal
Department of Pathology, Toronto General Hospital, University Health Network, Toronto, ON M5G2C4, Canada. adriana.luk@mail.utoronto.ca.
Adriana
A
Luk
Department of Pathology, Toronto General Hospital, University Health Network, Toronto, ON M5G2C4, Canada. vivek.rao@uhn.ca.
Vivek
V
Rao
Department of Pathology, Toronto General Hospital, University Health Network, Toronto, ON M5G2C4, Canada. jagdish.butany@uhn.on.ca.
Jagdish
J
Butany
D015415:Biomarkers; D006338:Heart Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D009232:Myxoma / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism
D015415:Biomarkers